179 related articles for article (PubMed ID: 10639360)
1. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.
Walker DJ; Pitsch JL; Peng MM; Robinson BL; Peters W; Bhisutthibhan J; Meshnick SR
Antimicrob Agents Chemother; 2000 Feb; 44(2):344-7. PubMed ID: 10639360
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis.
Dutta GP; Bajpai R; Vishwakarma RA
Pharmacol Res; 1989; 21(4):415-9. PubMed ID: 2771860
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.
Witkowski B; Lelièvre J; Nicolau-Travers ML; Iriart X; Njomnang Soh P; Bousejra-Elgarah F; Meunier B; Berry A; Benoit-Vical F
PLoS One; 2012; 7(3):e32620. PubMed ID: 22403683
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite.
Pandey AV; Tekwani BL; Singh RL; Chauhan VS
J Biol Chem; 1999 Jul; 274(27):19383-8. PubMed ID: 10383451
[TBL] [Abstract][Full Text] [Related]
5. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I
Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426
[TBL] [Abstract][Full Text] [Related]
6. Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.
Robert A; Claparols C; Witkowski B; Benoit-Vical F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3998-4000. PubMed ID: 23752508
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line.
Ferrer-Rodríguez I; Pérez-Rosado J; Gervais GW; Peters W; Robinson BL; Serrano AE
J Parasitol; 2004 Feb; 90(1):152-60. PubMed ID: 15040683
[TBL] [Abstract][Full Text] [Related]
8. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization.
Kannan R; Sahal D; Chauhan VS
Chem Biol; 2002 Mar; 9(3):321-32. PubMed ID: 11927257
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin antimalarials: mechanisms of action and resistance.
Meshnick SR
Med Trop (Mars); 1998; 58(3 Suppl):13-7. PubMed ID: 10212891
[TBL] [Abstract][Full Text] [Related]
10. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1997 Mar; 91(2):141-5. PubMed ID: 9307655
[TBL] [Abstract][Full Text] [Related]
11. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
Chawira AN; Warhurst DC
J Trop Med Hyg; 1987 Feb; 90(1):1-8. PubMed ID: 3546715
[TBL] [Abstract][Full Text] [Related]
12. Qinghaosu resistance in rodent malaria.
Chawira AN; Warhurst DC; Peters W
Trans R Soc Trop Med Hyg; 1986; 80(3):477-80. PubMed ID: 3541309
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1999 Jun; 93(4):325-9. PubMed ID: 10656034
[TBL] [Abstract][Full Text] [Related]
14. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 2000 Jan; 94(1):23-35. PubMed ID: 10723521
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sodium artesunate on Plasmodium yoelii analysed by flow cytometry].
Han WS; Zhou WQ; Wang BX; Li ZM; Zuo LF; Guo JW
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(3):204-7. PubMed ID: 1307277
[TBL] [Abstract][Full Text] [Related]
16. The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding.
Bhisutthibhan J; Philbert MA; Fujioka H; Aikawa M; Meshnick SR
Eur J Cell Biol; 1999 Sep; 78(9):665-70. PubMed ID: 10535309
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin: mechanisms of action, resistance and toxicity.
Meshnick SR
Int J Parasitol; 2002 Dec; 32(13):1655-60. PubMed ID: 12435450
[TBL] [Abstract][Full Text] [Related]
18. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.
Afonso A; Hunt P; Cheesman S; Alves AC; Cunha CV; do Rosário V; Cravo P
Antimicrob Agents Chemother; 2006 Feb; 50(2):480-9. PubMed ID: 16436700
[TBL] [Abstract][Full Text] [Related]
19. Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates.
Tirrell AR; Vendrely KM; Checkley LA; Davis SZ; McDew-White M; Cheeseman IH; Vaughan AM; Nosten FH; Anderson TJC; Ferdig MT
Malar J; 2019 Aug; 18(1):295. PubMed ID: 31462253
[TBL] [Abstract][Full Text] [Related]
20. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
